Compare DPZ & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DPZ | KRYS |
|---|---|---|
| Founded | 1960 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 9.9B |
| IPO Year | 2004 | 2017 |
| Metric | DPZ | KRYS |
|---|---|---|
| Price | $354.06 | $358.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 11 |
| Target Price | ★ $434.29 | $297.60 |
| AVG Volume (30 Days) | ★ 957.5K | 544.1K |
| Earning Date | 04-27-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | 5.27 | ★ 128.00 |
| EPS | ★ 8.21 | 1.83 |
| Revenue | ★ $4,939,994,000.00 | $389,130,000.00 |
| Revenue This Year | $7.98 | $38.74 |
| Revenue Next Year | $3.97 | $32.53 |
| P/E Ratio | ★ $41.84 | $192.25 |
| Revenue Growth | 4.96 | ★ 33.94 |
| 52 Week Low | $282.00 | $130.50 |
| 52 Week High | $477.00 | $382.54 |
| Indicator | DPZ | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 69.81 | 56.41 |
| Support Level | $346.31 | $246.17 |
| Resistance Level | $418.07 | $382.33 |
| Average True Range (ATR) | 13.18 | 18.29 |
| MACD | 4.28 | -2.27 |
| Stochastic Oscillator | 91.39 | 63.42 |
Domino's is the world's largest pizza chain, surpassing $20 billion in system sales with over 22,100 stores across more than 90 markets at the end of 2025. Around 33% of its units are in the US. The business is 99% franchised. Domino's operates through three segments: supply chain (60% of revenue), US stores (33%), and international franchises (7%). The firm generates the bulk of its revenue by supplying food to stores in the US and Canada through a vertically integrated network of 25 manufacturing and supply chain facilities, which primarily produce and distribute dough, and collecting brand royalties and marketing fees from franchisees. Domino's also generates revenue from sales at company-owned stores.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.